Product
Methylene Blue
Aliases
Azul de Metileno, Azul Metile, Blu di Metilene, CI-52015, CI Basic Blue 9 (11 other aliases)
13 clinical trials
21 indications
Indication
Acquired MethaemoglobinaemiaIndication
Postoperative DeliriumIndication
Postoperative Cognitive DysfunctionIndication
Septic shockIndication
Neonatal SepsisIndication
ShockIndication
SepticemiaIndication
DENTAL IMPLANTSIndication
LASERIndication
Acute Kidney InjuryIndication
AbscessIndication
Diabetic Foot UlcersIndication
Diabetic WoundIndication
CancerIndication
Oral PainIndication
StomatitisIndication
Breast CancerIndication
Vasoplegic SyndromeIndication
Liver TransplantIndication
Methylene BlueIndication
SepsisClinical trial
Open Label Clinical Study to Evaluate the Safety and Efficacy of ProvayBlueTM (Methylene Blue) for the Treatment of Acquired MethemoglobinemiaStatus: Completed, Estimated PCD: 2020-08-31
Clinical trial
Effectiveness and Safety of Methylene Blue for Prevention of Postoperative Neurocognitive Disorders in Patients Undergoing Pancreatic Tumor Surgery: A Prospective Randomized Controlled Clinical TrialStatus: Completed, Estimated PCD: 2023-04-30
Clinical trial
Comparative Study Between High and Low Dose Methylene Blue Infusion in Septic Cancer Patients. A Randomized Blinded Controlled StudyStatus: Recruiting, Estimated PCD: 2024-02-29
Clinical trial
Intravenous Methylene Blue for Treating Fluid-refractory, Catecholamine-resistant, Neonatal Septic Shock: a Randomized, Placebo-controlled, Superiority TrialStatus: Not yet recruiting, Estimated PCD: 2026-03-14
Clinical trial
Clinical and Microbiologic Outcomes of Adjunctive Antimicrobial Photodynamic Therapy in the Non-surgical Treatment of Peri-implant DiseaseStatus: Completed, Estimated PCD: 2022-12-06
Clinical trial
Methylene Blue for the Prevention of Hypotension During Hemodialysis: a Randomized Open Label TrialStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
A Phase 1 Study to Assess Safety and Feasibility of Methylene Blue Photodynamic Therapy to Sterilize Deep Tissue Abscess CavitiesStatus: Completed, Estimated PCD: 2023-09-01
Clinical trial
The Effect of Combination Therapy of Oral Methylene Blue and Platelet-rich Plasma-fibrin Glue in Patients With Non-healing Diabetic Foot Ulcer: a Pilot StudyStatus: Recruiting, Estimated PCD: 2023-08-21
Clinical trial
A Phase 2 Study to Assess Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue AbscessesStatus: Not yet recruiting, Estimated PCD: 2029-12-01
Clinical trial
Randomized Controlled Trial Comparing 4 Intervention Arms, Including 3 Different Concentrations of Methylene Blue Oral Rinse Combined With Conventional Therapy and Conventional Therapy, in Patients With Intractable Pain Associated With Oral MucositisStatus: Completed, Estimated PCD: 2022-02-03
Clinical trial
French, Prospective, Post-marketing Study to Describe the Use, Detection Performance and Safety Profile of Infracyanine® (Indocyanine Green) for Breast Cancer Patients Undergoing a Sentinel Lymph Node (SLN) Biopsy.Status: Completed, Estimated PCD: 2023-11-06
Clinical trial
The Efficacy of Intravenous Hydroxocobalamin Versus Methylene Blue as Treatment for Intraoperative Vasoplegic Syndrome in Liver Transplant PatientsStatus: Completed, Estimated PCD: 2023-02-27
Clinical trial
Exploratory Study on the Efficacy and Safety of Methylene Blue in Treating Severe Septic Shock Patients: A Prospective, Randomized, Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2026-06-20